Gaming Disorder (GD) in ICD-11- Training clinicians
A webinar of the EPA Addictive Behaviours Section, in collaboration with the EPA Digital Psychiatry Section, and the International Society of Addiction Medicine (ISAM)
The EPA is pleased to announce the webinar “Gaming Disorder (GD) in ICD-11- Training clinicians”, taking place on Wednesday, 19 November 2025, from 16:30 to 18:00 CET. This webinar is organised by the EPA Addictive Behaviours Section, in collaboration with the EPA Digital Psychiatry Section and the International Society of Addiction Medicine (ISAM).
details
Title: Gaming Disorder (GD) in ICD-11- Training clinicians
Date: Wednesday 19 November 2025
Time: 16:30 – 18:00 CET
Platform: Zoom
Registrations: Open
KEY LEARNING OBJECTIVES
• Understand Gaming Disorder (GD) as a new ICD-11 mental health condition.
• Learn how to use the ICD-11 online browser to diagnose GD.
• Apply practical approaches for clinical assessment of GD.
• Recognize and manage comorbid health conditions associated with GD.
• Explore available online and e-health treatment options for GD.
Programme
16:00 – 16:05 | Alex Baldacchino (WPA & Sophia Achab (EPA)-Welcome and Introduction
16:05 – 16:20 | Marc N. Potenza– Description and boundaries of Gaming Disorder
16:20 – 16:35 | Sophia Achab – Diagnostic and clinical assessment in practice
16:35 – 16:50 | Sophia Achab – Treatment of Gaming Disorder
16:50 – 17:05 | Laura Orsolini– E-health treatment options for Gaming Disorder
17:05 – 17:20 | Q&A and Discussion
17:20 – 17:30 | Alex Baldacchino (WPA & Sophia Achab (EPA)-Wrap-up and conclusions
ABSTRACT
This webinar aims to provide clinicians with practical training on Gaming Disorder (GD), a newly recognized mental health condition included in the WHO’s ICD-11 under “disorders due to addictive behaviours.” Moderated by Alex Baldacchino (UK) and Sophia Achab (Switzerland), the session will feature international experts presenting on the definition, clinical assessment, comorbidities, and treatment options for GD.
Marc N. Potenza (USA) will open with an overview of the description, epidemiology, and diagnostic boundaries of GD, setting the foundation for understanding its place in ICD-11. Sophia Achab (Switzerland) will then focus on the diagnostic process and clinical assessment of GD, illustrating the use of the ICD-11 browser and practical guidance for clinical work. She will explore the common comorbidities observed in individuals with GD, including neurodevelopmental and other mental health conditions, and their implications for care. Finally, Laura Orsolini (Italy) will present on digital health and e-treatment options for GD, highlighting innovative, accessible, and evidence-based approaches.
The session will conclude with a clinical case discussion, where the audience will be invited to bring forward real-world questions to be addressed collectively with the panel.
Moderators
- Alex Baldacchino, MD, PhD, University of St Andrews, UK; WPA Addiction Section Chair, ISAM Past Immediate President – Biography
- Sophia Achab, MD, University of Geneva, Switzerland; EPA, WPA, ISAM, WHO Collaborating Centre for Training and Research in Mental Health – Biography
Speakers
- Marc N. Potenza, MD, PhD, Yale University, USA – Description and boundaries of GD – Biography
- Sophia Achab, MD, University of Geneva, Switzerland – Diagnostic and clinical assessment in practice
- Laura Orsolini, MD, Università Politecnica delle Marche, Italy – E-health treatment options for GD – Biography